DAVID HIRSCH

Profile

First Name

: DAVID

Middle Name

:

Last Name

: HIRSCH

Related Companies
Titles
Company Name
Related People
DIRECTOR
NCRX OPTICAL SOLUTIONS INC
PATRICK COOK, LARRY SIDERS, JOHN TRAINA
DIRECTOR
PRECISION THERAPEUTICS INC
JOEL P. ADAMS, JEFF CRISAN, TODD C. DAVIS, CLARKE B. FUTCH, MIKE GABRIN, HOLLY H. GALLION, M.D., DAVID R. HEILMAN, KEVIN JOHNSON, SHARON KIM, RICHARD S. KOLLENDER, STANLEY N. LAPIDUS, SEAN MCDONALD, MATTHEW T. REBER
DIRECTOR
TURIYA MEDIA, INC.
JOHN CHENG, RICH HEITZMANN, CHETHAN RAMACHANDRAN
DIRECTOR
CIVITAS THERAPEUTICS, INC.
GLENN BATCHELDER, RICHARD BATYCKY, ANDREA FRANZ, MARTIN FREED, ROB HOPFNER, ROBERT HOPFNER, MARK IWICKI, BLAIR JACKSON, AIDAN KING, TIMOTHY S. NELSON, ROBERT ROCHE, ROBERT P. ROCHE, JR., RAJEEV SHAH, TIM SHANNON, TIMOTHY SHANNON, BRYAN STUART, MARY TAYLOR
DIRECTOR
COLLEGIUM PHARMACEUTICAL INC
GAREN BOHLIN, PAUL BRANNELLY, JOSEPH CIAFFONI, SCOTT DREYER, JOHN A FALLON, ALISON B. FLEMING, PATRICK FORTUNE, JOHN FREUND, MICHAEL HEFFERNAN, PATRICK HERON, STEPHEN HOFFMAN, ROBERT W. JEVON, SHIRLEY KUHLMANN, GWEN A MELINCOFF, ERAN NADAV, GINO SANTINI, THEODORE SCHROEDER, MATTHEW STROBECK, STEVEN N. TANNENBAUM
DIRECTOR
SONGZA, INC.
PETER ASBILL, JOSHUA BOLTUCH, STEVE BOOM, ELLIOT BREECE, ELLIOTT BREECE, TIM KOMADA, ELIAS ROMAN, DAVID SHEARER, CHAN SUH
DIRECTOR
RAPID MICRO BIOSYSTEMS, INC.
MARK BRAGANZA, CHRISTOPHER CASHMAN, CHRISTOPHER M CASHMAN, CHRISTOPHER M. CASHMAN, MARK G CIPRIANO, MARK G. CIPRIANO, BRUCE COHEN, FRED COHEN, STEPHEN DELITY, STEPHEN H DELITY, STEPHEN H. DELITY, MICHAEL ELLIS, RICHARD KOLLENDER, RICHARD S. KOLLENDER, LUC MARENGERE, WILLIAM MOFFITT, THOMAS P MONATH, THOMAS P. MONATH, TOM MONATH, MICHAEL J MULLEN, MICHAEL J. MULLEN, P. SHERRILL NEFF, LORIN RANDALL, NATALE RICCIARDI, JEFFREY SCHWARTZ, ROBERT SPIGNESI, DON STRAUS, DONALD STRAUS, SEAN WIRTJES
EXECUTIVE OFFICER
METAMORPHIC VENTURES II, L.P.
LEWIS D. GERSH, N/A METAMORPHIC VENTURES MANAGEMENT II, LLC, MARC MICHEL
EXECUTIVE OFFICER
METAMORPHIC VENTURES II-A, L.P.
N/A METAMORPHIC VENTURES MANAGEMENT II, LLC, MARC MICHEL
DIRECTOR
VOYAT INC.
BENJAMIN HABBEL, BOB LUND, MORTEN LUND
DIRECTOR
LAUNCHKEY, INC.
DEVIN EGAN, GEOFF SANDERS, GEOFFREY RICHARD SANDERS, YO SUB KWON
EXECUTIVE OFFICER
ONEX YORK CO-INVEST LP
TIMOTHY A.R. DUNCANSON, KONSTANTINE GILIS, CHRISTOPHER A. GOVAN, JOSHUA S. HAUSMAN, EWOUT R. HEERSINK, ROBERT M. LE BLANC, DONALD W. LEWTAS, DAVID J. MANSELL, SETH M. MERSKY, ANTHONY MORGAN, ANTHONY MUNK, N/A ONEX PARTNERS GP INC., N/A ONEX PARTNERS MANAGER GP ULC, N/A ONEX PARTNERS MANAGER LP, TAWFIQ POPATIA, GERALD W. SCHWARTZ, NIGEL WRIGHT
DIRECTOR
COLLEGIUM PHARMACEUTICAL, INC
GAREN BOHLIN, PAUL BRANNELLY, JOSEPH CIAFFONI, SCOTT DREYER, JOHN A FALLON, ALISON B. FLEMING, PATRICK FORTUNE, JOHN FREUND, MICHAEL HEFFERNAN, PATRICK HERON, STEPHEN HOFFMAN, ROBERT W. JEVON, SHIRLEY KUHLMANN, GWEN A MELINCOFF, ERAN NADAV, GINO SANTINI, THEODORE SCHROEDER, MATTHEW STROBECK, STEVEN N. TANNENBAUM
DIRECTOR
MOVE LOOT, INC.
WILLIAM BOBBITT, PETE FLINT, JENNY KARIN MORRILL, SHRUTI SHAH, RYAN SMITH
EXECUTIVE OFFICER
METAMORPHIC VENTURES FD, LLC
N/A METAMORPHIC VENTURES MANAGEMENT II, LLC, MARC MICHAEL
DIRECTOR
VELICEPT THERAPEUTICS, INC.
JAMES BENNETHUM, CORY S. FREEDLAND, CORY FREEDMAN, DOUG GESSL, DOUGLAS GESSL, DAVID HIRSCH, M.D., AIDAN KING, AIDAN KING, MBA, CFA, JILL BECKER MAST, SCOTT MORENSTEIN, STEPHEN TULLMAN, JAMES WALKER, JAMES C. WALKER
DIRECTOR
GROOP INTERNET PLATFORM INC.
PATRICK CONROY, JEFFERY CROWE, ALEX FINKELSTEIN, OREN FRANK, RONI FRANK, RAN HARNEVEO, JORDAN LEVY, GIL MARGOLIN, ANDREW SEKEL, EREZ SHACHAR
DIRECTOR
ZAVANTE THERAPEUTICS, INC.
EVELYN J. ELLIS-GROSSE, KEVIN FINNEY, CAM GALLAGHER, CAM GARNER, CAM L. GARNER, PATRICK HERON, THEODORE R. SCHROEDER
DIRECTOR
TRICIDA, INC.
ROBERT ALPERN, DAVID BONITA, JERRY BUYSSE, SANDRA COUFAL, EDWARD HEJLEK, GERRIT KLAERNER, CLAIRE LOCKEY, MELISSA MIKSCH, GEOFFREY PARKER, WILHELM STAHL, KLAUS VEITINGER
DIRECTOR
MOLECULAR TEMPLATES, INC.
JEFFREY W. BIRD, MICHAEL BROXSON, BRUCE C. COZADD, JOHN G. CURD, ADAM D. CUTLER, JOEL A. FERNANDES, GABRIELA GRUIA, WILLIAM A. HALTER, DAVID HOFFMAN, DAVID HOFFMANN, DAVID R. HOFFMANN, WILFRED E. JAEGER, JASON KIM, JASON S. KIM, STEWART M. KROLL, KEVIN LALANDE, KEVIN M. LALANDE, JONATHAN LANFEAR, MARK D. MATTEUCCI, SCOTT MORENSTEIN, ERIC E. POMA, ERIC ROGERS, CORSEE SANDERS, HAROLD E. SELICK, DAVID VALACER, ROGER WALTZMAN, ROGER J. WALTZMAN
DIRECTOR
POSEIDA THERAPEUTICS, INC.
RAFAEL AMADO, CHARLES M. BAUM, NOAH BERKOWITZ, CYNTHIA COLLINS, LUKE CORNING, NISHAN DE SILVA, LARS EKMAN, MARK GERGEN, MARK J. GERGEN, ADRIAN HOWD, HARRY J. LEONHARDT, MARCEA B. LLOYD, MARCEA BLAND LLOYD, ROBERT LYONS, CATHERINE J. MACKEY, SEAN MURPHY, JOHANNA M. MYLET, ERIC OSTERTAG, JOHN SCHMID, MATTHEW SPEAR, BRENT WARNER, KRISTIN YAREMA
DIRECTOR
AMUNIX PHARMACEUTICALS, INC.
JAMES BRUSH, RICHARD HEYMAN, TRISHA MILLICAN, VOLKER SCHELLENBERGER, OTELLO STAMPACCHIA, JAMES TOPPER, ANGIE YOU
DIRECTOR
SWIFT HOLDCO LTD
RICHARD GARMAN, SEAN GIESE, JAMES GREENE, KYLE GRISWOLD, RICHARD LIU, ROBERT MCCULLEN, GABRIEL MOYNAGH
DIRECTOR
WKCGRG HOLDINGS, INC.
BOB GIACALONE, COLIN GIACALONE, SCOTT HAVENS, WILLIAM KRAMER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-24
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-17 
2021-12-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2021-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-01-07 
2020-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-06-17 
2020-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-28 
2019-12-03
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2019-11-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2019-08-14
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-12 
2019-04-22
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-03-19 
2018-11-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-11-08 
2018-07-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-12 
2018-05-02
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-12 
2018-04-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-19 
2017-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2017-04-20
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2016-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-12 
2016-06-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-31 
2016-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-24 
2015-12-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-11-05
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2015-10-14 
2015-07-20
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-06 
2015-05-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-21 
2015-04-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-15 
2015-03-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2015-03-09 
2015-03-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-06 
2015-02-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-28 
2014-12-24
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-12 
2014-11-24
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-19 
2014-08-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-08-22 
2014-05-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-12 
2014-04-11
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-01 
2014-03-19
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2012-07-06 
2014-03-19
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2012-07-06 
2013-10-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-27 
2013-09-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-03 
2013-07-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-25 
2013-07-03
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2012-07-06 
2013-04-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-29 
2012-02-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-10 
2011-05-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-27 
2011-03-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-08 
2011-01-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-27 
2010-06-04
D
Link
OTHER HEALTH CARE 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2010-05-25 
2009-11-25
D
Link
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2009-11-17